Literature DB >> 26678830

Mouse models of adrenocortical tumors.

Kaitlin J Basham1, Holly A Hung1, Antonio M Lerario1, Gary D Hammer2.   

Abstract

The molecular basis of the organogenesis, homeostasis, and tumorigenesis of the adrenal cortex has been the subject of intense study for many decades. Specifically, characterization of tumor predisposition syndromes with adrenocortical manifestations and molecular profiling of sporadic adrenocortical tumors have led to the discovery of key molecular pathways that promote pathological adrenal growth. However, given the observational nature of such studies, several important questions regarding the molecular pathogenesis of adrenocortical tumors have remained. This review will summarize naturally occurring and genetically engineered mouse models that have provided novel tools to explore the molecular and cellular underpinnings of adrenocortical tumors. New paradigms of cancer initiation, maintenance, and progression that have emerged from this work will be discussed.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adrenal cortex; Adrenal hyperplasia; Adrenal tumor model; Adrenocortical carcinoma; Gonadectomy-induced tumorigenesis; Spontaneous adrenal tumor

Mesh:

Substances:

Year:  2015        PMID: 26678830      PMCID: PMC4720156          DOI: 10.1016/j.mce.2015.11.031

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  173 in total

1.  GONADECTOMY AND ADRENAL NEOPLASMS.

Authors:  G W Woolley; E Fekete; C C Little
Journal:  Science       Date:  1943-03-26       Impact factor: 47.728

2.  Distribution of steroidogenic enzymes involved in androgen synthesis in polycystic ovaries: an immunohistochemical study.

Authors:  E M Kaaijk; H Sasano; T Suzuki; J F Beek; F van Der Veen
Journal:  Mol Hum Reprod       Date:  2000-05       Impact factor: 4.025

3.  SF-1 overexpression in childhood adrenocortical tumours.

Authors:  Mara A D Pianovski; Luciane R Cavalli; Bonald C Figueiredo; Savana C L Santos; Mabrouka Doghman; Raul C Ribeiro; Antonio G Oliveira; Edson Michalkiewicz; Giovanna A Rodrigues; Gerard Zambetti; Bassem R Haddad; Enzo Lalli
Journal:  Eur J Cancer       Date:  2006-03-29       Impact factor: 9.162

4.  Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates.

Authors:  L Barzon; C Scaroni; N Sonino; F Fallo; M Gregianin; C Macrì; M Boscaro
Journal:  J Clin Endocrinol Metab       Date:  1998-01       Impact factor: 5.958

5.  A polymorphic form of steroidogenic factor-1 is associated with adrenocorticotropin resistance in y1 mouse adrenocortical tumor cell mutants.

Authors:  Claudia Frigeri; Jennivine Tsao; Martha Cordova; Bernard P Schimmer
Journal:  Endocrinology       Date:  2002-10       Impact factor: 4.736

6.  Gonadotropins are essential modifier factors for gonadal tumor development in inhibin-deficient mice.

Authors:  T R Kumar; Y Wang; M M Matzuk
Journal:  Endocrinology       Date:  1996-10       Impact factor: 4.736

7.  Transgenic GATA-4 expression induces adrenocortical tumorigenesis in C57Bl/6 mice.

Authors:  Marcin Chrusciel; Susanna Vuorenoja; Bidut Mohanty; Adolfo Rivero-Müller; Xiangdong Li; Jorma Toppari; Ilpo Huhtaniemi; Nafis A Rahman
Journal:  J Cell Sci       Date:  2013-02-26       Impact factor: 5.285

8.  Cyclin D2 and p27 are tissue-specific regulators of tumorigenesis in inhibin alpha knockout mice.

Authors:  Kathleen H Burns; Julio E Agno; Piotr Sicinski; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2003-07-10

9.  TASK channels determine pH sensitivity in select respiratory neurons but do not contribute to central respiratory chemosensitivity.

Authors:  Daniel K Mulkey; Edmund M Talley; Ruth L Stornetta; Audra R Siegel; Gavin H West; Xiangdong Chen; Neil Sen; Akshitkumar M Mistry; Patrice G Guyenet; Douglas A Bayliss
Journal:  J Neurosci       Date:  2007-12-19       Impact factor: 6.167

10.  Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy.

Authors:  J P Luton; S Cerdas; L Billaud; G Thomas; B Guilhaume; X Bertagna; M H Laudat; A Louvel; Y Chapuis; P Blondeau
Journal:  N Engl J Med       Date:  1990-04-26       Impact factor: 91.245

View more
  5 in total

1.  DLK1/PREF1 marks a novel cell population in the human adrenal cortex.

Authors:  Irene Hadjidemetriou; Katia Mariniello; Gerard Ruiz-Babot; James Pittaway; Alessandra Mancini; Demetris Mariannis; Celso E Gomez-Sanchez; Laila Parvanta; William M Drake; Teng-Teng Chung; Tarek Ezzat Abdel-Aziz; Aimee DiMarco; Fausto F Palazzo; Margaret E Wierman; Katja Kiseljak-Vassiliades; Peter J King; Leonardo Guasti
Journal:  J Steroid Biochem Mol Biol       Date:  2019-06-29       Impact factor: 4.292

Review 2.  Update on in-vivo preclinical research models in adrenocortical carcinoma.

Authors:  Adwitiya Kar; Margaret E Wierman; Katja Kiseljak-Vassiliades
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2020-06       Impact factor: 3.243

Review 3.  Cystic adrenal lesions: focus on pediatric population (a review).

Authors:  Mara Carsote; Adina Ghemigian; Dana Terzea; Ancuta Augustina Gheorghisan-Galateanu; Ana Valea
Journal:  Clujul Med       Date:  2017-01-15

4.  Wnt/β-catenin activation cooperates with loss of p53 to cause adrenocortical carcinoma in mice.

Authors:  Kleiton Silva Borges; Emanuele Pignatti; Sining Leng; Dulanjalee Kariyawasam; Gerard Ruiz-Babot; Fernando Silva Ramalho; Makoto Mark Taketo; Diana L Carlone; David T Breault
Journal:  Oncogene       Date:  2020-06-19       Impact factor: 9.867

5.  Establishment of a mouse xenograft model of metastatic adrenocortical carcinoma.

Authors:  Aurélie Morin; Carmen Ruggiero; Estelle Robidel; Mabrouka Doghman-Bouguerra; Atze T Das; Rémy Castellano; Emmanuelle Josselin; Judith Favier; Enzo Lalli
Journal:  Oncotarget       Date:  2017-04-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.